How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene AcquisitionThe Motley Fool • 12/21/19
Gilead Sciences Reinforces Yescarta Commercial Product With Latest, Long-Term Survival FindingsSeeking Alpha • 12/16/19
Gilead Stock Is Among The Biggest Biotech Stocks - But Should You Buy It?Investors Business Daily • 12/06/19
3 Big Stock Charts for Thursday: Gilead Sciences, DocuSign and Western DigitalInvestorPlace • 11/14/19